Evidence map›Paper›PMID 40868025›Full record

ArticleAntibiotics (Basel, Switzerland)2025

FTIR-Derived Feature Insights for Predicting Time-Dependent Antibiotic Resistance Progression.

Mitchell Bonner, Claudia P Barrera Patiño, Andrew Ramos Borsatto, Jennifer M Soares, Kate C Blanco, Vanderlei S Bagnato

Abstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mitchell BonnerBiomedical Engineering, Texas A&M University, 400 Bizzell St, College Station, TX 77843, USA.ORCID 0009-0001-3119-9986
Claudia P Barrera PatiñoBiomedical Engineering, Texas A&M University, 400 Bizzell St, College Station, TX 77843, USA.ORCID 0000-0002-3233-1109
Andrew Ramos BorsattoBiomedical Engineering, Texas A&M University, 400 Bizzell St, College Station, TX 77843, USA.ORCID 0009-0005-3852-4648
Jennifer M SoaresBiomedical Engineering, Texas A&M University, 400 Bizzell St, College Station, TX 77843, USA.ORCID 0000-0002-2978-7076
Kate C BlancoSao Carlos Institute of Physics, University of Sao Paulo, IFSC-USP, Sao Carlos 13566-590, SP, Brazil.ORCID 0000-0003-0361-9725
Vanderlei S BagnatoBiomedical Engineering, Texas A&M University, 400 Bizzell St, College Station, TX 77843, USA.ORCID 0000-0003-4833-239X

Funding

Cancer Prevention and Research Institute of Texas CPRIT 353 RR220054CRI 02-292034Fundação de Amparo à Pesquisa do Estado de São Paulo FAPESP 024/00100-0 and 2023/17384-8Governor's University Research Initiative GURI M230930
6 · The paper itself

Abstract

BACKGROUND/

objectivesThe progression of antibiotic resistance is increasingly recognized as a dynamic and time-dependent phenomenon, challenging conventional diagnostics that define resistance as a binary trait.

methodsBiomolecules have fingerprints in Fourier-transform infrared spectroscopy (FTIR). The targeting of specific molecular groups, combined with principal component analysis (PCA) and machine learning algorithms (ML), enables the identification of bacteria resistant to antibiotics.

resultsIn this work, we investigate how effective classification depends on the use of different numbers of principal components, spectral regions, and defined resistance thresholds. Additionally, we explore how the time-dependent behavior of certain spectral regions (different biomolecules) may demonstrate behaviors that, independently, do not capture a complete picture of resistance development. FTIR spectra were obtained from

conclusionsThese results indicate that antibiotic resistance should be viewed as a temporally adaptive trajectory rather than a static state. FTIR-based biochemical profiling, when integrated with ML, enables projection of phenotypic transitions and supports real-time therapeutic decision-making. This strategy represents a shift toward adaptive antimicrobial management, with the potential to personalize interventions based on dynamic resistance monitoring through spectral biomarkers.

Indexed as

antibiotic-resistant bacteriaprediction modelStaphylococcus aureus

Identifiers

PMID40868025
PMCPMC12382883

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.